Pharmacists must take reasonable steps to identify a patient, patient’s representative, practitioner or pharmacist before providing pharmacy services.
As per section 36 of the Pharmacy Operations and Drug Scheduling Act (PODSA) bylaws (PDF, 258KB), pharmacists “must take reasonable steps to confirm the identity of a patient, patient's representative…before providing any pharmacy service that requires accessing, using or disclosing patient personal health information.”
The College of Pharmacists of BC (CPBC) Professional Practice Policy 54–Identifying Patients and Patient Representatives in Community Pharmacy and Telepharmacy Settings (PDF, 155KB) establishes that
The CPBC Professional Practice Policy 54–Identifying Patients and Patient Representatives in Community Pharmacy and Telepharmacy Settings (PDF, 210KB) lists these examples of primary identification:
The CPBC Professional Practice Policy 54 (PDF, 210KB) lists these examples of secondary identification:
Different identification requirements apply when managing patient protective words. (i.e., when applying, removing or changing a protective word on the patient’s own PharmaNet record).
Refer to Section 9.6 – Protective Words for details.
Pharmacies should report suspicious requests for pharmacy or client information to the PharmaCare Help Desk. They should refuse phone requests for such information if they cannot identify the caller.
HIBC never contacts pharmacies for pharmacist credentials or other identifying information. Such requests are often an attempt to obtain drugs illegally or commit identity theft. If someone calls a pharmacy claiming to be from PharmaCare, PharmaNet or HIBC, pharmacies should call the PharmaCare Help Desk to make sure the call is from them before engaging.
When you call the PharmaCare Help Desk, please be prepared to provide information to prove your identity. HIBC carefully screens callers to help prevent misuse of pharmacy or pharmacist information.
CPBC Professional Practice Policy 54—Identifying Patients and Patient Representatives in Community Pharmacy and Telepharmacy Settings (PDF, 178KB)